RO93784B1 - General anaesthesis method - Google Patents

General anaesthesis method

Info

Publication number
RO93784B1
RO93784B1 RO121002A RO12100285A RO93784B1 RO 93784 B1 RO93784 B1 RO 93784B1 RO 121002 A RO121002 A RO 121002A RO 12100285 A RO12100285 A RO 12100285A RO 93784 B1 RO93784 B1 RO 93784B1
Authority
RO
Romania
Prior art keywords
general
infusion
anaesthesis
known manner
patient
Prior art date
Application number
RO121002A
Other languages
Romanian (ro)
Other versions
RO93784A2 (en
Inventor
Ion Petre Artur Tica
Ghita Evlampia Albulescu
Ana Maria Handabureac
Dora Mary Vania Tica
Vlad Iustin Tica
Andrei Adrian Tica
Original Assignee
Spitalul Clinic Judetean Nr.1
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spitalul Clinic Judetean Nr.1 filed Critical Spitalul Clinic Judetean Nr.1
Priority to RO121002A priority Critical patent/RO93784B1/en
Publication of RO93784A2 publication Critical patent/RO93784A2/en
Publication of RO93784B1 publication Critical patent/RO93784B1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Metoda de anestezie generala, conform inventiei, consta în aceea ca se intubeaza pacientul endotraheal, sub protectie de tiobarbituric-leptocurara în mod cunoscut, se administreaza, intravenos si într-o singura priza, 1...2,5 mg/kg corp pentazocina, apoi imediat se administreaza prin perfuzie în glucoza izotonica 0,3 mg dihidroergotoxina ce se perfuzeaza cu un anumit debit, curarizarea pacientului si ventilarea este sistematica si se face în mod cunoscut, iar dozele se pot repeta în situatia interventiilor de durata mai lunga.The general anesthetic method according to the invention consists in the intubation of the endotracheal patient under the protection of thiobarbituric-leptocurbar in a known manner, intravenously and in a single inlet, 1 ... 2.5 mg / kg pentasocine body , then infusion into isotonic glucose is immediately administered by infusion of 0.3 mg of dihydroergotoxin, which is perfused with a certain flow rate, the patient's curriculum and ventilation is systematic and is known in a known manner and the doses can be repeated in the situation of longer duration interventions.

RO121002A 1985-12-03 1985-12-03 General anaesthesis method RO93784B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RO121002A RO93784B1 (en) 1985-12-03 1985-12-03 General anaesthesis method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RO121002A RO93784B1 (en) 1985-12-03 1985-12-03 General anaesthesis method

Publications (2)

Publication Number Publication Date
RO93784A2 RO93784A2 (en) 1988-02-29
RO93784B1 true RO93784B1 (en) 1988-03-01

Family

ID=20118399

Family Applications (1)

Application Number Title Priority Date Filing Date
RO121002A RO93784B1 (en) 1985-12-03 1985-12-03 General anaesthesis method

Country Status (1)

Country Link
RO (1) RO93784B1 (en)

Also Published As

Publication number Publication date
RO93784A2 (en) 1988-02-29

Similar Documents

Publication Publication Date Title
EP0269804A3 (en) Flow controller
DE3371745D1 (en) Inhalation valve
WO2000037110A3 (en) Ribavirin-pegylated interferon alfa induction hcv combination therapy
EP0246715A3 (en) Apparatus for the safe delivery of a beneficial agent to a patient
EP0341258A4 (en) Improved interferon therapy
ATE105718T1 (en) MEDICATION ADMINISTRATION SYSTEM.
CA2114014A1 (en) Advanced Drug Delivery System and Method of Treating Psychiatric, Neurological and Other Disorders with Carbamazepine
MY117781A (en) Combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection
PL345959A1 (en) Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate
JPS56104815A (en) Remedy for peripheral orthostatic hypotension
NZ510811A (en) Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
HUP9901768A2 (en) Parenteral fluid delivery bag with integral line set
MD990258A (en) Method of treatment of the acute viral hepatitis B
Araki et al. Excretion of 14C‐formaldehyde distributed systemically through root canal following pulpectomy
EP0227356A3 (en) The use of depogen in the treatment of restricted blood circulation
GR3006999T3 (en)
DE3470842D1 (en) Arrangement in a catheter unit with attachment wings, for infusion cannulas
ATE47664T1 (en) PHARMACEUTICAL DOSING UNIT.
RO102780B1 (en) General anaesthesia method
Cranin et al. Synergistic basal narcosedation: A basic technique employing promethazine, meperidine, and secobarbital
Pollock et al. Synergistic actions of carbon dioxide with DDT in the central nervous system
SU1168252A1 (en) Method of treatment of patients ill with psoriasis
JPS5718618A (en) Antitumor agent
RU98109203A (en) METHOD FOR TREATING VIRAL HEPATITIS B IN CHILDREN
UA33160A (en) Method for intensive therapy of paranoid schizophrenia